BACKGROUND: When policymakers make decision about the target populations and timing of influenza vaccination, they may not consider the impact on the vaccine supply chains, which may in turn affect vaccine availability. PURPOSE: Our goal is to explore the effects on the Thailand vaccine supply chain of introducing influenza vaccines and varying the target populations and immunization time-frames. METHODS: We Utilized our custom-designed software HERMES (Highly Extensible Resource for Modeling Supply Chains), we developed a detailed, computational discrete-event simulation model of the Thailand's National Immunization Program (NIP) supply chain in Trang Province, Thailand. A suite of experiments simulated introducing influenza vaccines for different target populations and over different time-frames prior to and during the annual influenza season. RESULTS: Introducing influenza vaccines creates bottlenecks that reduce the availability of both influenza vaccines as well as the other NIP vaccines, with provincial to district transport capacity being the primary constraint. Even covering only 25% of the Advisory Committee on Immunization Practice-recommended population while administering the vaccine over six months hinders overall vaccine availability so that only 62% of arriving patients can receive vaccines. Increasing the target population from 25% to 100% progressively worsens these bottlenecks, while increasing influenza vaccination time-frame from 1 to 6 months decreases these bottlenecks. CONCLUSION: Since the choice of target populations for influenza vaccination and the time-frame to deliver this vaccine can substantially affect the flow of all vaccines, policy-makers may want to consider supply chain effects when choosing target populations for a vaccine.
BACKGROUND: When policymakers make decision about the target populations and timing of influenza vaccination, they may not consider the impact on the vaccine supply chains, which may in turn affect vaccine availability. PURPOSE: Our goal is to explore the effects on the Thailand vaccine supply chain of introducing influenza vaccines and varying the target populations and immunization time-frames. METHODS: We Utilized our custom-designed software HERMES (Highly Extensible Resource for Modeling Supply Chains), we developed a detailed, computational discrete-event simulation model of the Thailand's National Immunization Program (NIP) supply chain in Trang Province, Thailand. A suite of experiments simulated introducing influenza vaccines for different target populations and over different time-frames prior to and during the annual influenza season. RESULTS: Introducing influenza vaccines creates bottlenecks that reduce the availability of both influenza vaccines as well as the other NIP vaccines, with provincial to district transport capacity being the primary constraint. Even covering only 25% of the Advisory Committee on Immunization Practice-recommended population while administering the vaccine over six months hinders overall vaccine availability so that only 62% of arriving patients can receive vaccines. Increasing the target population from 25% to 100% progressively worsens these bottlenecks, while increasing influenza vaccination time-frame from 1 to 6 months decreases these bottlenecks. CONCLUSION: Since the choice of target populations for influenza vaccination and the time-frame to deliver this vaccine can substantially affect the flow of all vaccines, policy-makers may want to consider supply chain effects when choosing target populations for a vaccine.
Authors: Bruce Y Lee; Tina-Marie Assi; Jayant Rajgopal; Bryan A Norman; Sheng-I Chen; Shawn T Brown; Rachel B Slayton; Souleymane Kone; Hailu Kenea; Joel S Welling; Diana L Connor; Angela R Wateska; Anirban Jana; Ann E Wiringa; Willem G Van Panhuis; Donald S Burke Journal: Am J Public Health Date: 2011-11-28 Impact factor: 9.308
Authors: William M Trochim; Derek A Cabrera; Bobby Milstein; Richard S Gallagher; Scott J Leischow Journal: Am J Public Health Date: 2006-01-31 Impact factor: 9.308
Authors: Lucia Helena de Oliveira; M Carolina Danovaro-Holliday; Cuauhtemoc Ruiz Matus; Jon Kim Andrus Journal: Expert Rev Vaccines Date: 2008-04 Impact factor: 5.217
Authors: Bryan A Norman; Jayant Rajgopal; Jung Lim; Katrin Gorham; Leila Haidari; Shawn T Brown; Bruce Y Lee Journal: Vaccine Date: 2015-05-06 Impact factor: 3.641
Authors: Leslie E Mueller; Leila A Haidari; Angela R Wateska; Roslyn J Phillips; Michelle M Schmitz; Diana L Connor; Bryan A Norman; Shawn T Brown; Joel S Welling; Bruce Y Lee Journal: Vaccine Date: 2016-05-21 Impact factor: 3.641
Authors: Beverly D Bradley; Tiffany Jung; Ananya Tandon-Verma; Bassem Khoury; Timothy C Y Chan; Yu-Ling Cheng Journal: Health Res Policy Syst Date: 2017-04-18
Authors: Leila A Haidari; Diana L Connor; Angela R Wateska; Shawn T Brown; Leslie E Mueller; Bryan A Norman; Michelle M Schmitz; Proma Paul; Jayant Rajgopal; Joel S Welling; Jim Leonard; Sheng-I Chen; Bruce Y Lee Journal: PLoS One Date: 2013-05-22 Impact factor: 3.240